Beta Thalassemia Major: Clinical Trials

2 trials for Beta Thalassemia Major, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2
Phase 21Unknown 1

Follow Beta Thalassemia Major: new trials by email Literature Review of Beta Thalassemia Major trials Research Report on Beta Thalassemia Major

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders
Sofosbuvir and Ledipasvir - HCV Infection, Beta Thalassemia Major
Phase 3UnknownAin Shams University242018-06-112023-03-06
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Deferiprone - Beta Thalassemia Major
Phase 2 / Phase 3UnknownAin Shams University642014-07-012015-01-14

Narrower conditions

beta-Thalassemia (2)  ·  Hepatitis C (1)

Broader conditions

Anemia (2)  ·  Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemoglobinopathies (2)  ·  Thalassemia (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)

Interventions

Deferiprone (1)  ·  ledipasvir, sofosbuvir drug combination (1)

Sponsors

Ain Shams University (2)

Countries

Egypt (2)

Top investigators

Manal H El-Sayed, M.D (1)  ·  Mohsen S Elalfy, professour (1)

Results publications

PMID 29119631, PMID 34186262, PMID 37975597